Skip to content
Main menu
  • about
    • Who we are
    • Hydrix Group
    • Board & Executive
    • Careers
    • Corporate Governance
  • markets
    • Cardiac & MedTech
    • Regulatory & Clinical
    • Industrial & Defence
  • services
  • our work
  • news & articles
  • investors
  • contact
news & articles
  • Hydrix Medical sponsors an international symposium on the AngelMed Guardian
  • Hydrix announces first in human trials of Phyzhon Health’s PHYRARI FFR-WIRE
  • Developing the CORIS360™, a new radiation imaging solution
  • Hydrix announces exclusive agreement to distribute novel cardiovascular technology
  • Online Event - AusBiotech 2020 Australia's largest Life Science conference
  • Acknowledging our team's dedication and hard-work during COVID-19
  • Implantation of Next-Generation AngelMed Guardian® commences in US
  • SEMMA Webinar Recording - Necessity is the mother of… manufacturing
  • Hydrix and Memphasys awarded 2020 Good Design Awards for the Felix™ ART/IVF technology
  • Update on AngelMed Guardian implants in Singapore
  • First AngelMed Guardian implants in Asia-Pacific for Hydrix Medical
  • Venstra Medical secures $850K grant for miniature heart pump development
  • Introducing the world-first heart attack alerting technology
  • WEBINAR - Navigating manufacturing regulations for medical equipment/supplies
  • Regulatory Insights for Device Manufacturers During the COVID-19 Pandemic
  • Hydrix joins Australian COVID-19 Ventilator Team
  • Brad Phillips joins the Board of the Australian Innovation Research Group (AIRG)
  • Introducing Hydrix Medical, a member of the Hydrix Group
  • WEBINAR - Regulatory and IP Strategies in the time of COVID-19
  • New Product Development and COVID-19
  • Safety Critical Software for Autonomous Mining Systems
  • Paul Kelly, cardiac technologies innovator
  • Meet Alejandro Lara, Product Designer
  • Applying innovation for safety and productivity gains in mining
  • World-first heart attack alerting technology to be launched in Australia
  • Co-locating your start-up at Hydrix
  • Meet the team - Yael Rosenberg, Software Group Manager
  • Meet the team - Tajanka Mladenovska, Regulatory Affairs
  • Applying structured innovation to deliver wins in the mining industry
  • Angel Medical Systems partners with Hydrix to develop unique heart attack alert technology
  • APAS Independence wins top design award
  • Mission accomplished as ACRUX-1 sends signals from Low Earth Orbit
  • Innovating with confidence in next generation cardiac devices
  • Hydrix and Melbourne Space Program announce MOU
  • Hydrix joins AusMedtech committee
  • Micro-X Good Design Award

Online Event - AusBiotech 2020 

AusBiotech + Invest 2020 – Australia’s largest life science conference is back and will be delivered online live 28 – 30 October.  Michelle Knight, Regulatory & Clinical Manager at Hydrix, will be participating in a panel event on “The role of digital health in clinical trials”.

Make sure to register and join Michelle on Wednesday 28 October, 3:30 pm. 

Register Now

About Michelle

Michelle is the Clinical and Regulatory Manager at Hydrix Limited and is a qualified Audiologist and Certified Professional with the Association of Clinical Research Professionals. She is an experienced clinical program manager in identifying the scope and requirements of clinical evidence to support global regulatory, marketing and reimbursement needs.

If you would like to view the full event programme click here

Ready to explore how we can help?

Let's talk

 

Tell us which area(s) you're interested in

Hydrix

Address: 30-32 Compark Circuit Mulgrave, Vic, 3170

Phone: +61 3 9550 8100

Follow us on LinkedIn :

Back to top
Footer
  • Designed & Powered by Web Force 5